A

ATAI Life Sciences NV
D

ATAI

1.98000
USD
-0.05
(-2.46%)
مغلق
حجم التداول
221,170
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
384,105,889
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: ATAI Life Sciences NV

القطاع: Healthcare
الصناعة: Biotechnology
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.